CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-γ and tumour necrosis factor-α in response to the recombinant 14KDA Schistosoma mansoni fatty acid-binding protein

Scandinavian Journal of Immunology

Volumn 51, Issue 6, 2000, Pages 595-601

  Brito, C F A ^a   Caldas, I R ^b   Coura Filho, P ^b   Correa Oliveira, R ^b   Oliveira, Sergio Costa ^c,d  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d Ctro Pesq R Rachou Fund O Cruz   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FATTY ACID BINDING PROTEIN; GAMMA INTERFERON; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 10; SCHISTOSOMA VACCINE SM14; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION RESISTANCE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; PARASITE IMMUNITY; PRIORITY JOURNAL; SCHISTOSOMIASIS; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGED; ANIMALS; CARRIER PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CYTOKINES; FATTY ACID TRANSPORT PROTEINS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; FEMALE; HELMINTH PROTEINS; HUMANS; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MYELIN P2 PROTEIN; NEOPLASM PROTEINS; RECOMBINANT PROTEINS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS;

EID: 0034041384     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00710.x     Document Type: Article

References (40)

1. 1 Bergquist NR. Schistosomiasis vaccine development: approaches and prospects. Mem Inst Oswalde Cruz 1995;90:221-7.
2. 2 Tendler M, Brito CA, Vilar MM et al. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc Natl Acad Sci USA 1996;93:269-73.
3. + T-cell subsets in the regulation of parasite immunity and disease. Immunol Rev 1989;112:161-82.
4. 4 Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon or IL-4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T-cell subsets. J Exp Med 1989;169:59-72.
5. 5 Wilson RA. Immunity and immunoregulation in helminth infections. Curr Opin Immunol 1993;5:538-47.
6. 6 Locksley RM. Th2 cells: help for helminths. J Exp Med 1994;179:1405-7.
7. 7 Butterworth AE. Immunological aspects of human schistosomiasis. Br Med Bull 1998;54:357-68.
8. 8 Hagan P, Blumenthal UJ, Dunn D, Simpson AJG, Wilkins HA. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991;349:243-5.
9. 9 Smythies LE, Coulson P, Wilson RA. Monoclonal antibody to IFN-γ modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. J Immunol 1992;149:3654-8.
10. 10 James SL. Activated macrophages as effector cells of protective immunity to schistosomiasis. Immunol Res 1986;5:139-48.
11. 11 Vianna IRC, Sher A, Carvalho OS et al. Interferon-γ production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Trans Roy Soc Med Hyg 1994;88:466-70.
12. 12 Joseph AL, Boros DL. Tumour necrosis factor plays a role in Schistosoma mansoni egg-induced granulomatous inflammation. J Immunol 1993;151:5461-71.
13. 13 Adewusi OI, Nix NA, Lu X, Colley DG, Secor WE. Schistosoma mansoni: Relationship of tumour necrosis factor-α to morbity and collagen deposition in chronic experimental infection. Exp Parasit 1996;84:115-23.
14. 14 Oswald IP, Wynn TA, Sher A, James SL. Interleukin-10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumour necrosis factor a required as a costimulatory factor for interferon γ-induced activation. Proc Natl Acad Sci USA 1992;89:8676-80.
15. 15 Gazzinelli RT, Oswald IP, James SL, Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J Immunol 1992;148:1792-6.
16. 16 Correa-Oliveira R, Pearce EJ, Oliveira GC et al. The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil. Trans Roy Soc Med Hyg 1989;83:1205-11.
17. 17 Colley DG, Cook JA, Freeman GL, Bartholomew RK, Jordan P. Immune responses during human schistosomiasis mansoni. i. In vitro lymphocyte blastogenic responses to heterogeneous antigenic preparations from schistosome eggs, worms and cercariae. Int Arch Allergy Appl Immunol 1977;53:420-33.
18. 18 Lowry OH, Rosenbrough N, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
19. 19 Gazzinelli G, Katz N, Rocha RS, Colley DG. Immune response during human schistosomiasis mansoni. X. Production and standardization of an antigen-induced mitogenic activity by peripheral blood mononuclear cells from treated, but not active cases of schistosomiasis. J Immunol 1983;130:2981-5.
20. 20 Bahia-Oliveira LMG, Simpson AJG, Alves-Oliveira LF et al. Evidence that cellular immune responses to soluble and membrane associated antigens are independently regulated during human schistosomiasis mansoni. Parasite Immunol 1996;18:53-63.
21. 21 Jung T, Schauer U, HeusSeries C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Meth 1993;159:197-207.
22. 22 Sander B, Andersson J, Andersson U. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol Rev 1991;119:65-93.
23. 23 Sher A, Coffman RL, Hieny S, Scott P, Cheever AW. Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci USA 1990;87:61-5.
24. 24 Medhat A, Shehata M, Bucci K et al. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J Inf Dis 1998;178:512-9.
25. 25 King CL, Medhat A, Malhotra I et al. Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity. J Immunol 1996;156:4715-21.
26. 26 Bahia-Oliveira LMG, Gazzinelli G, Eloi-Santos SM et al. Differential cellular reactivity to adult worm antigens of patients with different clinical forms of schistosomiasis mansoni. Trans Roy Soc Med Hyg 1992;86:57-61.
27. 27 Correa-Oliveira R, Malaquias LCC, Falcão PL et al. Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection. Braz J Med Biol Res 1998;31:171-7.
28. 28 Montenegro SM, Miranda P, Mahanty S et al. Cytokine production in acute versus chronic human Schistosomiasis mansoni: the cross-regulatory role of interferon-gamma and interleukin-10 in the responses of peripheral blood mononuclear cells and splenocytes to parasite antigens. J Infect Dis 1999;179:1502-14.
29. + cells after chemotherapy in human Schistosoma haematobium infection. Eur J Immunol 1996;26:1365-70.
30. 30 Araújo MI, de Jesus AR, Bacellar O, Sabin E, Pearce E, Carvalho EM. Evidence of a T helper type 2 activation in human schistosomiasis. Eur J Immunol 1996;26:1399-403.
31. 31 Malaquias LCC, Falcão PL, Silveira AMS et al. Cytokine regulation of immune response to Schistosoma mansoni: analysis of the role of IL-4, IL-5 and IL-10 on peripheral blood mononuclear cell responses. Scand J Immunol 1997;46:393-8.
32. 32 Sternberg JM, Mabbott NA. Nitric oxide-mediated suppression of T cell responses during Trypanosoma brucei infection: soluble trypanosome products and interferon-γ are synergistic inducers of nitric oxide synthase. Eur J Immunol 1996;26:539-43.
33. 33 Liew FY. The role of nitric oxide in parasite diseases. Ann Trop Med Parasitol 1993;87:637-42.
34. 34 Jacobs P, Radzioch D, Stevenson MM. In vivo regulation of nitric oxide production by tumour necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice. Infect Immun 1996;64:44-9.
35. 35 Martins-Filho OA, Dutra WO, Freeman GL et al. Flow cytometric study of blood leucocytes in clinical forms of human schistosomiasis. Scand J Immunol 1997;46:304-11.
36. 36 Mountford AP, Coulson PS, Pemberton RM, Smythies LE, Wilson RA. The generation of interferon-gamma-producing T lymphocytes in the skin-draining lymph nodes, and their recruitment to the lungs, is associated with protective immunity to Schistosoma mansoni. Immunology 1992;75:250-6.
37. 37 Wilson RA. Interferon gamma is a key cytokine in lung phase immunity to schistosomes but what is its precise role? Braz J Med Biol Res 1998;31:157-61.
38. 38 Hoffmann KF, Caspar P, Cheever AW, Wynn TA. IFN-gamma, IL-12, and TNF-alpha are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12. J Immunol 1998;161:4201-10.
39. 39 Ahmed SF, Oswald IP, Caspar P et al. Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni. Infect Immun 1997;65:219-26.
40. 40 Janecharut T, Hata H, Takahashi H, Yoshida S, Saito H, Kojima S. Effects of recombinant tumour necrosis factor on antibody-dependent eosinophil-mediated damage to Schistosoma japonicum larvae. Parasite Immunol 1992;14:605-16.